Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.23.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets and Liabilities

Significant components of the Company’s deferred income taxes at December 31, 2022 and 2021 are shown below (table in thousands):

 

    2022     2021  
Deferred tax assets:                
Net operating loss carryforwards   $ 21,368     $ 19,993  
Compensation     474       846  
Research and development tax credits     2,710       2,423  
Capitalized and Research Expenditures     2,595       -  
Other     487       466  
Total deferred tax assets     27,633       23,728  
                 
Deferred tax liabilities:                
Property and equipment     (27 )     (21 )
Other     (60 )     (105 )
Total deferred tax liabilities     (87 )     (126 )
                 
Total deferred taxes, net     27,546       23,602  
Valuation allowance     (27,546 )     (23,602 )
                 
Deferred tax liability, net   $ -     $ -  
Schedule of Reconciliation of Federal Statutory Income Tax Rate

A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

    2022     2021  
             
Statutory federal income tax rate     21.0 %     21.0 %
Goodwill impairment     (10.3 )%     0 %
Research credits     0.7 %     1.9 %
Change in valuation allowance     (10.2 )%     (22.3 )%
Equity     (1.4 )%     0.0 %
Other tax, credit and adjustments     0.2 %     (0.6 )%
Effective income tax rate     0.0 %     0.0 %